Zika-related nerve damage caused by immune response to the virus

November 20, 2017
Zika virus particles (red) shown in African green monkey kidney cells. Credit: NIAID

The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients with Zika-related complications, such as Guillain-Barré syndrome, the researchers said.

In mice models lacking a key antiviral response, infection with Zika virus causes paralysis and death. To understand the mechanism, a research team led by immunobiologist Akiko Iwasaki examined the spread of infection in these mice.

The research team found that when the Zika infection spreads from the circulating blood into the brain, immune cells known as CD8 T cells flood the brain. While these T cells sharply limit the infection of nerve cells, they also trigger Zika-related paralysis, the researchers said.

"The that are generated by infection start attacking our own neurons," Iwasaki said. "The damage is not occurring through the , but rather the to the virus."

Immune-mediated nerve damage underlies Guillen-Barré syndrome, which affects some people infected with the Zika virus. The study findings suggest that suppressing the immune response might be an approach to treating the syndrome, which causes weakness, tingling, and, in rare cases, paralysis.

The study is published in Nature Microbiology.

Explore further: Findings add to evidence of association between Zika virus and Guillain-Barre syndrome

More information: Kellie A. Jurado et al, Antiviral CD8 T cells induce Zika-virus-associated paralysis in mice, Nature Microbiology (2017). DOI: 10.1038/s41564-017-0060-z

Related Stories

Findings add to evidence of association between Zika virus and Guillain-Barre syndrome

October 17, 2017
An examination of cases of Guillain-Barré syndrome in Puerto Rico identified Zika virus infection as a risk factor, according to a study published by JAMA.

How antibodies access neurons to fight infection

May 18, 2016
Yale scientists have solved a puzzle of the immune system—how antibodies enter the nervous system to control viral infections. Their finding may have implications for the prevention and treatment of a range of conditions, ...

Mouse model could shed new light on immune system response to Zika virus

February 23, 2017
A new mouse model with a working immune system could be used in laboratory research to improve understanding of Zika virus infection and aid development of new treatments, according to a study published in PLOS Pathogens.

Researchers identify potential Zika virus target

May 4, 2017
New research provides insights into why infection with Zika virus after birth generally causes only mild symptoms, whereas devastating fetal malformations can develop when infection occurs during pregnancy.

Research provides clues to how Zika virus breaches the placental barrier

September 15, 2016
New research reveals that in pregnant women, Zika virus infection damages certain cells that affect placental formation and function. Furthermore, herpes simplex virus-2 (HSV-2) infection augments placental sensitivity to ...

Zika virus: Five things to know

February 8, 2016
A concise "Five things to know about.... Zika virus infection" article for physicians highlights key points about this newly emerged virus in CMAJ (Canadian Medical Association Journal)

Recommended for you

The immune cells that help tumors instead of destroying them

December 12, 2017
Lung cancer is the leading cause of cancer-associated deaths. One of the most promising ways to treat it is by immunotherapy, a strategy that turns the patient's immune system against the tumor. In the past twenty years, ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017
PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Researchers bring new insight into Chediak-Higashi syndrome, a devastating genetic disease

December 12, 2017
A team of researchers from the National Institutes of Health and University of Manchester have uncovered new insights into a rare genetic disease, with less than 500 cases of the disease on record, which devastates the lives ...

Drug increases speed, safety of treatment for multiple food allergies

December 11, 2017
In a randomized, controlled phase-2 clinical trial, an asthma medication increased the speed and safety of a protocol used to treat children for several food allergies at once, according to a study by researchers at the Stanford ...

Immunotherapy drug nearly eliminates severe acute graft-versus-host disease

December 9, 2017
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening ...

Location, location, location: Immunization delivery site matters

December 1, 2017
In vaccination, a certain subpopulation of dendritic cells is vital to triggering the body's adaptive immune system, report researchers at The Jackson Laboratory (JAX), Yale University and Astra-Zeneca.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.